Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clint Cary

Showing results (91-100 of 123) with videos related to

Pageof 13
Sort By:
Urologic Oncology|July 12, 2021
Definitive surgical therapy for refractory radiation cystitis: Evaluating effectiveness, tolerability, and extent of surgical approachIsamu Tachibana, Adam C Calaway, Zain Abedali, et al.
American Journal of Men'S Health|October 10, 2022
A Call to Action to Review the USPSTF's Recommendation for Testicular Self-ExaminationMichael J Rovito, Keri Allen, Ajay Nangia, et al.
European Urology|October 4, 2022
Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Isamu Tachibana, Sean Q. Kern, Antoin Douglawi, et al. Primary Retroperitoneal Lymph Node Dissection for Patients with Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary? J Clin Oncol. In press. https://doi.org/10.1200/JCO.22.00118: Is Retroperitoneal Lymph Node Dissection Without Adjuvant Chemotherapy Enough for All Patients with Pathologic Stage II Nonseminoma Germ Cell Tumor?Isamu Tachibana, Sean Q Kern, Antoin Douglawi, et al.
Urologic Oncology|September 26, 2022
Can Retroperitoneal Lymph Node Dissection (RPLND) be feasibly performed to prolong survival in Renal Cell Carcinoma (RCC) with limited lymph node involvement? An Analysis of Recurrence PatternsIsamu Tachibana, Ruben Vasquez, Mohammad Mahmoud, et al.
Urology|March 4, 2014
Plasmacytoid bladder cancer: variant histology with aggressive behavior and a new mode of invasion along fascial planesHristos Z Kaimakliotis, M Francesca Monn, Liang Cheng, et al.
Urology Practice|August 10, 2023
Does Squamous Differentiation Portend Worse Outcomes in Urothelial Bladder Cancer?David Y Yang, M Francesca Monn, Hristos Z Kaimakliotis, et al.
European Urology Open Science|September 15, 2022
Oncological Follow-up Strategies for Testicular Germ Cell Tumours: A Narrative ReviewErnest Kaufmann, Luca Antonelli, Peter Albers, et al.
Seminars in Pediatric Surgery|November 25, 2023
Critical elements of pediatric testicular germ cell tumors surgeryAmanda F Saltzman, Patrick Hensley, Jonathan Ross, et al.
Urologic Oncology|October 31, 2025
Comparison of 4 local anesthetic techniques for open radical cystectomy: A prospective, randomized controlled trialJiping Zeng, Isamu Tachibana, Josh Sadowski, et al.
JNCI Cancer Spectrum|March 20, 2020
Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical ManagementVaibhav Agrawal, Paul C Dinh, Chunkit Fung, et al.
Pageof 13

Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
Urologic Oncology|July 12, 2021
Definitive surgical therapy for refractory radiation cystitis: Evaluating effectiveness, tolerability, and extent of surgical approachIsamu Tachibana, Adam C Calaway, Zain Abedali, et al.
American Journal of Men'S Health|October 10, 2022
A Call to Action to Review the USPSTF's Recommendation for Testicular Self-ExaminationMichael J Rovito, Keri Allen, Ajay Nangia, et al.
European Urology|October 4, 2022
Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Isamu Tachibana, Sean Q. Kern, Antoin Douglawi, et al. Primary Retroperitoneal Lymph Node Dissection for Patients with Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary? J Clin Oncol. In press. https://doi.org/10.1200/JCO.22.00118: Is Retroperitoneal Lymph Node Dissection Without Adjuvant Chemotherapy Enough for All Patients with Pathologic Stage II Nonseminoma Germ Cell Tumor?Isamu Tachibana, Sean Q Kern, Antoin Douglawi, et al.
Urologic Oncology|September 26, 2022
Can Retroperitoneal Lymph Node Dissection (RPLND) be feasibly performed to prolong survival in Renal Cell Carcinoma (RCC) with limited lymph node involvement? An Analysis of Recurrence PatternsIsamu Tachibana, Ruben Vasquez, Mohammad Mahmoud, et al.
Urology|March 4, 2014
Plasmacytoid bladder cancer: variant histology with aggressive behavior and a new mode of invasion along fascial planesHristos Z Kaimakliotis, M Francesca Monn, Liang Cheng, et al.
Urology Practice|August 10, 2023
Does Squamous Differentiation Portend Worse Outcomes in Urothelial Bladder Cancer?David Y Yang, M Francesca Monn, Hristos Z Kaimakliotis, et al.
European Urology Open Science|September 15, 2022
Oncological Follow-up Strategies for Testicular Germ Cell Tumours: A Narrative ReviewErnest Kaufmann, Luca Antonelli, Peter Albers, et al.
Seminars in Pediatric Surgery|November 25, 2023
Critical elements of pediatric testicular germ cell tumors surgeryAmanda F Saltzman, Patrick Hensley, Jonathan Ross, et al.
Urologic Oncology|October 31, 2025
Comparison of 4 local anesthetic techniques for open radical cystectomy: A prospective, randomized controlled trialJiping Zeng, Isamu Tachibana, Josh Sadowski, et al.
JNCI Cancer Spectrum|March 20, 2020
Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical ManagementVaibhav Agrawal, Paul C Dinh, Chunkit Fung, et al.
Pageof 13